SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · PPR

Validation of a Mitochondrial Polygenic Score for Parkinson’s Disease

· 2025-03-19

DOI: 10.1101/2025.03.18.25323898

Check source for accessPreprintOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

Background Mitochondrial dysfunction is a key player in Parkinson’s disease (PD) pathogenesis. Mitochondrial polygenic scores (MGS) may be associated with PD but require validation across diverse populations. Objective To validate the association between the MGS, PD status and age-at-onset (AAO) in idiopathic and LRRK2- PD across various ancestries. Methods We analyzed data from 17,129 PD patients and 13,872 healthy individuals across 10 ancestries within the Global Parkinson’s Disease Genetic Program. We used regression models to assess the association between MGS, PD status and AAO. Results The MGS was associated with iPD in Europeans (β=0.19, SE=0.02, pConclusions The MGS is robustly associated with iPD status in Europeans and Ashkenazi Jews and with LRRK2-PD status. Population-specific MGS are needed to improve accuracy in other ancestries.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.